CClinicalTrials.gg
CompletedNCT03998475Updated Nov 9, 2020

Transition Preparation Intervention for Young Adults With Type 1 Diabetes

An interventional study of Transition preparation intervention in Type 1 Diabetes, sponsored by Virginia Commonwealth University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-11-09.

Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.

Read the detailed description

The overarching goal of the proposed trial is to improve diabetes self-management and glycemic control in young adults and prepare them for the transition to adult endocrinology. The current application will investigate the impact of a multisystem transition preparation intervention for young adults (ages 18-22) with T1D. Twenty-five young adults and a parent will be enrolled in a 6-month transition preparation program which will use a hybrid in-person and technology delivery structure. Providers will receive training highlighting their role preparing young adults for transition and provides practical tips to use in their communication with young adults. If effective, this multisystem intervention, designed to enhance T1D self-management and increase young adults' readiness for transition to adult healthcare during this critical developmental period, has the potential to inform clinical practice guidelines.

02

Conditions studied

  • Type 1 Diabetes

Keywords

  • Transition
  • Young Adult
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 62 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Virginia Commonwealth University is the lead sponsor of 641 studies on the registry; 82 are open to participants now.

Of its 88 completed or terminated interventional studies of FDA-regulated products, 62 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Both members of the youth/parent dyad must meet all eligibility criteria

Young adults

  • English-speaking
  • patients in Pediatric Endocrinology at Children's Hospital of Richmond (CHoR) at Virginia Commonwealth University (VCU)
  • between ages 18-22 yrs with a
  • diagnosis of T1D for >1 year

Parents

  • greater than 18 years of age
  • provide care to the young adult with T1D
  • are willing to participate in the intervention

Medical providers

  • provide care to patients with T1D ages 18-22 yrs in Pediatric Endocrinology at CHoR

Exclusion criteria

Exclusion Criteria:

Young adults

  • significant psychiatric, cognitive, medical or developmental conditions that would impair their ability to complete assessments and/or engage in diabetes self-care behaviors (e.g., malignancies, psychosis, intellectual disability), as documented in the medical record or revealed during eligibility screening, or
  • medically-induced diabetes or diagnosis of diabetes other than type 1 diabetes

Parents

  • non-English speaking
  • psychiatric, cognitive, or developmental conditions that would impair their ability to complete assessments and/or engage in the intervention as determined at study screening
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Transition preparation program

    Transition preparation intervention for young adults with type 1 diabetes (T1D)

    Behavioral: Transition preparation intervention

Interventions

  • BehavioralTransition preparation intervention

    Young adult participants and parents will complete transition preparation sessions that include meeting with a health behavior coach for in-person sessions and review of materials sent electronically between study visits.

06

What researchers measure

Primary outcomes

  1. Number of sessions attended

    Number of study visits (attendance)

    Time frame: 6 months

  2. Number of session views

    Number of opened electronic materials (e.g., opened messages in the patient health portal))

    Time frame: 6 months

  3. Program acceptability - young adult

    Young adult report on satisfaction with the program via an exit survey

    Time frame: 9 months

  4. Program acceptability - parent

    Parent report on satisfaction with the program via an exit survey

    Time frame: 9 months

  5. Program acceptability - provider

    Provider report on satisfaction with the program via an exit survey

    Time frame: 9 months

Secondary outcomes

  1. Change in Glycemic control

    Measurement of hemoglobin A1c (A1c; reported as a percentage)

    Time frame: Baseline to 9 months

  2. Diabetes-related hospitalizations

    Participant report and medical record review of count of reported diabetes-related hospitalizations and complications

    Time frame: 9 months

  3. Change in adherence to diabetes care regimen

    Average of young adult and parent participant reports on the Diabetes Management Questionnaire (DMQ)

    Time frame: Baseline to 9 months

  4. Change in transition readiness

    Average of young adult and parent participant reports on the Transition Readiness Assessment Questionnaire (TRAQ)

    Time frame: Baseline to 9 months

Other outcomes

  1. Change in diabetes self-efficacy

    Participant (young adult) report on the Self-Efficacy for Diabetes Self-Management (SEDSM)

    Time frame: Baseline to 9 months

  2. Change in diabetes quality of life

    Participant (young adult) report on the Pediatric Quality of Life Diabetes Module

    Time frame: Baseline to 9 months

  3. Change in diabetes family responsibility

    Average of young adult and parent participant reports on the Diabetes Family Responsibility Questionnaire (DFRQ)

    Time frame: Baseline to 9 months

  4. Change in diabetes family conflict

    Average of young adult and parent participant reports on the Diabetes Family Conflict Scale (DFCS)

    Time frame: Baseline to 9 months

  5. Change in depression

    Participant (young adult) report on the Center for Epidemiologic Studies Depression Scale (CESD)

    Time frame: Baseline to 9 months

  6. Change in young adult diabetes distress

    Participant (young adult) report on the Diabetes Distress Scale

    Time frame: Baseline to 9 months

  7. Change in parent diabetes distress

    Participant (parent) report on the Diabetes Distress Scale for Parents of Teens with T1D

    Time frame: Baseline to 9 months

  8. Change in autonomy support

    Participant (young adult) report on the autonomy support sub-scale of the Barriers to Diabetes Adherence Questionnaire

    Time frame: Baseline to 9 months

  9. Change in problem solving

    Participant (young adult) report on the Diabetes Adherence Problem Solving Questionnaire

    Time frame: Baseline to 9 months

07

Study locations

1 site
  • Children's Hospital of Richmond at Virginia Commonwealth University
    Richmond, Virginia 23298, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03998475
Lead sponsor
Virginia Commonwealth University
Collaborators
American Diabetes Association
Responsible party
Sponsor
First posted
Jun 26, 2019
Start date
Jul 11, 2019
Primary completion
Sep 16, 2020
Completion
Sep 16, 2020
Last update
Nov 9, 2020

Study contacts

Laura Caccavale, PhD
principal investigator · Virginia Commonwealth University
Melanie Melanie, PhD
principal investigator · Virginia Commonwealth University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion